Two types of mutants highly sensitive to beta-Iactam antibiotics were obtained from Pseudomonas aeruginosa PAO 2142 by treatment with N-methyl-N'-nitro-N-nitrosoguanidine. One type of mutant showed over 30 times higher sensitivity to mecillinam, carbenicillin and sulbenicillin than did the parent, but not to most other beta-lactam antibiotics tested. In contrast, the other type mutant was about 30 times more sensitive to ampicillin, cephaloridine, cefoxitin and cefinetazole, but resistant to mecillinam, carbenicillin and sulbenicillin at the same level as the parent. Beta-lactamase activity of these mutants was not different from that of the parent. Defect in either of penicillin-binding proteins IA/1B or 5 was observed in some mutants of P. aerginnsa highly sensitive to beta-Iactam antibiotics.
). Considering the sensitivity for beta-lactam antibiotics, mutants obtained were classified into two types. Mutant hs-86 and 233, which were selected as strains sensitive to 2 mcg/ml of carbenicillin, 6-APA, Five ttl of cell suspension (10 6 CFU/ml) was inoculated onto heart infusion agar containing an appropriate concentration of drug and incubated for 20 hours at 30°C. Mutants hs-28 and hs-246 showed patterns of drug sensitivity similar to those of hs-208 and hs-257, although data are not shown. and piperacillin(PIPC) compared with that of the parent. They(type I) showed almost the same sensitivity as the parent to penicillin G (PC-G), cephaloridine(CER), cefoxitin(CFX) and cefinetazole(CMZ).
In contrast, mutants selected as a strain sensitive to at least one of 17 beta-lactam antibiotics tested among temperature-sensitive mutants(ts-mutants), for example hs-208, 246 and 257 (data for hs-246 not shown), showed more than 64 times higher sensitivity to CER, 32-128 times to ABPC, 32-64 times to PC-G and 1664 times to CFX and CMZ compared with that of the parent. The sensitivity of these mutants(type II) to MPC, CBPC, SBPC and TIPC was almost the same as that of the parent. Mutant hs-28, which was directly obtained on the plate with 100 mcg/ml of CFX, showed MICs similar to type II of the mutants(data not shown). Beta-lactam antibiotics to which type I mutants show high sensitivity were different from those for type II mutants.
Beta-lactamase less mutant bla-5, obtained by the other method, showed MIC patterns similar to type 11 mutants.
Intracellular beta-lactamase is known to play an important role in resistance to beta-lactam antibiotics, as a result of the fact that lack of production and inducibility of beta-lactamase has rendered cultures highly sensitive 2). Also in this experiment, beta-lactamase-less mutant bla -5, with a very low level of beta-lactamase activity (less than 5 x 10-` U/mg of protein), was con- (Tables 1 and 2 ). On the other hand, hs-mutants obtained in this experiment possessed almost the same activity (5 to 11 x 10-4 U/mg of protein) of beta-lactamase as that of the parent (Table 2) . By the addition of inducer (2 mg/ml of PC-G), betalactamase production has been increased up to the level of I to 9 x 10-z U/mg of protein in all the mutants except hs-28. The specific activity of hs-28 remained at the uninduced level, even in the presence of inducer (Table 2) . Mutant hs-28 seems to be lacking in inducibility.
[14C]PC-G binding to membrane preparation of mutants, followed by SDS-polyacrylamide gel electrophoresis and fluorography, disclosed that some hs-mutants have some defect in penicillin-binding proteins. In particular, hs-86 and 233 mutant(type I) possessed coincidentally altered electrophoretic mobilities of PBP-IA and 1B, the molecular weight of which was a little higher than those of the parent, as shown in Fig. 1 (data for hs-86 not shown) . PBP-IA and lB may presumably be cooperatively synthesized in vivo and these mutants may lack in the enzyme involved in the process of biosynthesis, for example, processing enzyme. Mutants hs-86 and 233 showed partly temperature-sensitive growth even though not selected by temperature. They could form colonies at 40°C, but not at 44°C, whereas the parent could grow even at 44°C. Although we tried to obtain spontaneous revertants of temperaturesensitivity or drug sensitivity to elucidate the relation of defects in PBPs with high sensitivity to a specific group of beta-lactam antibiotics or temperature sensitivity, we have been unsuccessful. These mutants, hs-86 and 233, showed over 10 times higher sensitivity to oxytetracycline, chloramphenicol, mitomycin C and nalidixic acid than did the parent and were sensitive to 100 mcg/ml of gentian violet, although they showed the same level of sensitivity as did the parent to rifampicin, actinomycin D, lysozyme and aminoglycosides such as kanamycin, streptomycin and gentamicin.
Another example of hs-mutants with altered PBP is hs-257. PBP-5 of this mutant moved a very little faster than that of parent on SDS-polyacrylamide gel electrophoresis and lost almost all of its [14Cl PC-G binding ability by treatment for 10 minutes at 40°C (Fig. 1, c and f) . This PBP-5 lacks activity for releasing [14C]PC-G from [14C]PC-G -protein complex even at 30°C and this mutant also lacks PC-G moderately sensitive D-alanine carboxypeptidase activity, which presumably corresponds to D-alanine carboxypeptidase lA of E. colic8) Detailed properties of hs-257 will be reported elsewhere. The growth of mutant hs-257 was inhibited by 100 mcg/ml of actinomycin D and 3.2 mg/ml of lysozyme, at which concentration the growth of the parent was not affected. It showed almost the same sensitivity as the parent to non-beta-lactam antibiotics such as oxytetracycline, chloramphenicol, mitomycin C, nalidixic acid, rifampicin, kanamycin, streptomycin, gentamicin and gentian violet.
The higher sensitivity of hs-mutants for some agents other than beta-lactam antibiotics would suggest that these mutants may have alteration in permeability of drugs through cell envelope, but examination of sensitivity to cell wall-specific phages revealed no difference between parent and hs-mutants obtained in this experiment.
Mutants defective in some PBP could be detected among hs-mutants of P. aeruginosa. Mutantss hs-233(86) and hs-257 may be useful to elucidate the function of PBP-lA • 1B and PBP-5, respectively, in P. aeruginosa. The correlation of defects and alteration in PBPs with high sensitivity to beta-lactam antibiotics is now under investigation.
